Augustine Lawlor insider trades: Catalyst Biosciences (CBIO) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Augustine reports to the SEC
and 8 more companies
Open-market buys and sales
20 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Feb 25, 2020 | CBIO | ↓ Sell | 69,401 | $6.10 | $424K | By HealthCare Ventures VIII, L.P. | Feb 25, 2020 (0d) |
| Feb 5, 2019 | LPTX | ↑ Buy | 571,428 | $1.75 | $1000K | Indirect | Feb 5, 2019 (0d) |
| Nov 14, 2017 | LPTX | ↑ Buy | 1,057,769 | $6.08 | $6.4M | Indirect | Nov 16, 2017 (2d) |
| Mar 18, 2016 | GBIM | ↓ Sell | 11,000 | $1.55 | $17K | By Partnership | Mar 18, 2016 (0d) |
| Mar 15, 2016 | GBIM | ↓ Sell | 2,500 | $2.05 | $5K | By Partnership | Mar 17, 2016 (2d) |
| Mar 11, 2016 | GBIM | ↓ Sell | 16,500 | $1.60 | $26K | By Partnership | Mar 14, 2016 (3d) |
| Mar 8, 2016 | GBIM | ↓ Sell | 15,010 | $1.05 | $16K | By Partnership | Mar 8, 2016 (0d) |
| Mar 3, 2016 | GBIM | ↓ Sell | 15,990 | $1.11 | $18K | By Partnership | Mar 3, 2016 (0d) |
| Feb 29, 2016 | GBIM | ↓ Sell | 15,000 | $0.98 | $15K | By Partnership | Feb 29, 2016 (0d) |
| Feb 24, 2016 | GBIM | ↓ Sell | 15,000 | $1.33 | $20K | By Partnership | Feb 24, 2016 (0d) |
| Feb 19, 2016 | GBIM | ↓ Sell | 15,000 | $1.44 | $22K | By Partnership | Feb 19, 2016 (0d) |
| Feb 17, 2016 | PTI | ↑ Buy | 375,000 | $8.00 | $3.0M | Indirect | Feb 17, 2016 (0d) |
| Feb 16, 2016 | GBIM | ↓ Sell | 15,000 | $1.61 | $24K | By Partnership | Feb 16, 2016 (0d) |
| Aug 21, 2014 | CSII | ↓ Sell | 361,235 | $28.05 | $10.1M | By HealthCare Ventures VI, L.P. | Aug 25, 2014 (4d) |
| Jul 8, 2014 | GBIM | ↑ Buy | 190,000 | $10.00 | $1.9M | By Partnership | Jul 8, 2014 (0d) |
| Feb 5, 2014 | TRVN | ↑ Buy | 297,058 | $7.00 | $2.1M | By Partnership | Feb 7, 2014 (2d) |
| Dec 17, 2013 | TLOG | ↑ Buy | 713,463 | $7.00 | $5.0M | Indirect | Dec 17, 2013 (0d) |
| Aug 3, 2007 | HAQ | ↑ Buy | 125,000 | $7.66 | $958K | Direct | Aug 7, 2007 (4d) |
| Aug 3, 2007 | HAQ | ↑ Buy | 125,000 | $7.66 | $958K | Direct | Aug 7, 2007 (4d) |
| Apr 12, 2007 | AVNC | ↑ Buy | 682,903 | $2.36 | $1.6M | Direct | Apr 13, 2007 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other CBIO insiders
Open-market trades in the last 12 months
About Augustine Lawlor's insider trades
Augustine Lawlor is an insider at Catalyst Biosciences (CBIO). Since Apr 12, 2007, Augustine has reported 9 open-market purchases worth $22.9M and 11 sales worth $10.7M on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (85 filings), other transactions (14 filings), conversions (6 filings), option exercises (3 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every CBIO insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.